T38.7 Poisoning by, adverse effect of and underdosing of androgens and anabolic congeners

Name of the Condition

• Poisoning by, adverse effect of and underdosing of androgens and anabolic congeners

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to androgens and anabolic congeners. These substances are used for various therapeutic purposes, including hormone replacement or anabolic effects, and the code covers scenarios where their use leads to harmful outcomes or insufficient therapeutic effect.

Causes

The causes include accidental or intentional overdose of androgens or anabolic agents, adverse reactions to prescribed or non-prescribed use, or inadequate dosing that fails to achieve the intended therapeutic effect. Underdosing may result from missed doses, incorrect administration, or subtherapeutic prescribing.

Risk Factors

• Use of androgen or anabolic therapies for medical conditions
• Polypharmacy involving hormonal agents
• Incorrect dosing or administration
• Individual sensitivity to androgenic substances
• Renal or hepatic impairment affecting drug metabolism

Symptoms

Symptoms vary based on the specific agent and scenario: poisoning may cause virilization (e.g., hirsutism, voice deepening), electrolyte imbalances, or cardiovascular effects; adverse effects can include hepatotoxicity or mood changes; underdosing may lead to inadequate therapeutic response for the intended indication.

Diagnosis

Diagnosis relies on a thorough medication history, clinical evaluation of symptoms, and laboratory testing to assess hormone levels or toxic effects. Documentation should specify the agent involved and the nature of the event (poisoning, adverse effect, or underdosing).

Treatment Options

Treatment depends on the severity and type of event. For poisoning, supportive care and antidote administration (if available) may be necessary. Adverse effects often require discontinuation or dose adjustment of the agent. Underdosing may be managed by optimizing dosing regimens or addressing adherence issues.

Prognosis and Follow-Up

Prognosis varies based on the extent of exposure or reaction. Mild cases may resolve with dose adjustment, while severe poisoning or adverse effects may require prolonged monitoring. Follow-up includes assessing therapeutic response or resolution of symptoms and adjusting treatment as needed.

Complications

Complications can include organ damage (e.g., liver toxicity), endocrine imbalances, or cardiovascular events, particularly with prolonged or high-dose exposure. Underdosing may lead to progression of the underlying condition being treated.

Lifestyle & Prevention

Prevention involves proper medication management, including adherence to prescribed dosing, avoiding non-prescribed use, and monitoring for adverse effects. Patients should be educated on the risks of androgenic agents and the importance of reporting unusual symptoms.

When to Seek Professional Help

Seek medical attention if symptoms of poisoning (e.g., severe virilization, organ dysfunction) or adverse effects (e.g., jaundice, mood changes) occur. Underdosing should be addressed if the underlying condition worsens or fails to improve with current therapy.

Tips for Medical Coders

Document the specific androgen or anabolic congener involved, the nature of the event (poisoning, adverse effect, or underdosing), and any contributing factors (e.g., incorrect dosing, non-adherence). Ensure the code aligns with clinical documentation and captures the full scope of the encounter.